1058705-60-4Relevant academic research and scientific papers
Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation
McElroy, William T.,Tan, Zheng,Ho, Ginny,Paliwal, Sunil,Li, Guoqing,Seganish, W. Michael,Tulshian, Deen,Tata, James,Fischmann, Thierry O.,Sondey, Christopher,Bian, Hong,Bober, Loretta,Jackson, James,Garlisi, Charles G.,Devito, Kristine,Fossetta, James,Lundell, Daniel,Niu, Xiaoda
supporting information, p. 677 - 682 (2015/06/30)
IRAK4 is a critical upstream kinase in the IL-1R/TLR signaling pathway. Inhibition of IRAK4 is hypothesized to be beneficial in the treatment of autoimmune related disorders. A screening campaign identified a pyrazole class of IRAK4 inhibitors that were d
AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES
-
, (2012/10/08)
This invention relates to amidopyrazole compounds that are inhibitors of Interleukin receptor-associated kinases, in particular IRAK-4, and are useful in the treatment of cellular proliferative diseases, for example, cancer, hyperplasia, restenosis, cardiac hypertrophy, immune disorders and inflammation.
